GLIOTRAIN achieves an "excellent" EC project check and the first annual meeting takes place

On October 23rd and 24th 2018 the 1st GLIOTRAIN annual meeting, followed by the EC Project Check took place. The Project Check, devised to take place 12 - 14 months into the Programme, ensures appropriate project progress. Management, PIs, students, associated post-doctoral researchers and the GLIOTRAIN Project Officer (from the European Commission) attended the two-day meeting. Ms Kathy Oliver, Prof Martin van den Bent and Prof Monika Hegi, GLIOTRAIN external advisory board members, were also present for the annual meeting.

GLIOTRAIN representatives participate in numerous outreach and public & patient involvement (PPI) events

In March 2018, GLIOTRAIN PI Dr Anna Golebiewska gave a talk to high school students in the framework of the 'Researcher at the School' initiative in Luxembourg. She introduced the everyday reality of being a researcher in academia. GLIOTRAIN students at the University of Stuttgart have also been partaking in outreach activities: In June 2018, Nivetha Krishna Moorthy featured in the Research Life Publication from the Universität Stuttgart in an Article called "Cancer Experts of tomorrow".

Dr Idbaih presents key results from Phase I study at ASCO 2018

In May 2018, Dr Ahmed Idbaih, GLIOTRAIN PI (ICM) presented at the American Society for Clinical Oncology (ASCO) 2018 meeting that took place in Chicago, IL. Dr Idbaih presented his talk entitled "Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM)".